Company news

MBX Biosciences, Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

MBX Biosciences Presents MBX 2109 Phase 2 Avail™ Hypoparathyroidism Trial Rationale and Design at the ASBMR 2024 Annual Meeting

September 29, 2024

MBX Biosciences Announces Closing of Upsized Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

September 15, 2024

MBX Biosciences Announces Pricing of Initial Public Offering

September 11, 2024

← Newer news releases

Calls

Decks

The 5 newest of 7 decks. Every deck is listed under its year.